Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
This study aims to evaluate the efficiency autologous nanofat injection versus autologous nanofat delivered by microneedling in management of post burn atrophic and traumatic scars.
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
| Label | Type | Description | Intervention Names |
|---|---|---|---|
| injection of autologous nanofat grafting | Experimental | Two separate scars with similar properties or splitting of one large post-burn atrophic scar. One (part of the) scar will be treated by injection of autologous nanofat grafting and the other (part of the) scar will be treated by microneedling with autologous nanofat graft. |
|
| microneedling with autologous nanofat graft | Experimental | Two separate scars with similar properties or splitting of one large post-burn atrophic scar. One (part of the) scar will be treated by injection of autologous nanofat grafting and the other (part of the) scar will be treated by microneedling with autologous nanofat graft. |
|
| Name | Type | Description | Arm Group Labels | Other Names |
|---|---|---|---|---|
| injection of autologous nanofat grafting | Procedure | Injection of nanfat graft |
|
| Measure | Description | Time Frame |
|---|---|---|
| change in the scar by by the patient and observer scar assessment scale (POSAS). | patient and observer scar assessment scale score will be uesd | 6 months after the proceedure |
Not provided
Not provided
Inclusion Criteria:
Exclusion Criteria:
1. Patients with contractures, hypertrophic and keloid scars. 2. Patients with history of bleeding disorders or coagulopathy, or on anticoagulant therpy.
3. Diabetes and other systemic diseases that may be complicated by the procedure.
4. Pregnant and lactating females. 5. BMI less than 18.5 6. Patients with scars at the donor site
Not provided
Not provided
Not provided
Not provided
| Name | Role | Phone | Extension | |
|---|---|---|---|---|
| Dalia I Halwag, PhD, MD | Contact | 0201224489473 | daliahalwag@gmail.com |
Not provided
| Facility | Status | City | State | ZIP | Country | Contacts |
|---|---|---|---|---|---|---|
| Alexandria University | Recruiting | Alexandria | Egypt |
Upon request and as compatible by ethical considerations
Upon request and as compatible by ethical considerations
Not provided
Not provided
Not provided
| ID | Term |
|---|---|
| D002921 | Cicatrix |
| ID | Term |
|---|---|
| D005355 | Fibrosis |
| D010335 | Pathologic Processes |
| D013568 | Pathological Conditions, Signs and Symptoms |
Not provided
Not provided
| ID | Term |
|---|---|
| D000097244 | Percutaneous Collagen Induction |
| ID | Term |
|---|---|
| D000529 | Complementary Therapies |
| D013812 | Therapeutics |
| D026741 | Physical Therapy Modalities |
| D011677 | Punctures |
Not provided
Not provided
To evaluate the efficiency autologous nanofat injection versus autologous nanofat delivered by microneedling in management of post burn atrophic and traumatic scars.
Not provided
Not provided
Not provided
Not provided
| microneedling with autologus nanofat graft | Procedure | delivery of nanofat graft with microneedling |
|
| D012046 |
| Rehabilitation |